Abbott Laboratories (ABT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 09:31AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 185.42B |
| Enterprise Value | 193.77B |
| Trailing P/E | 33.29 |
| Forward P/E | 22.99 |
| PEG Ratio (5 yr expected) | 5.82 |
| Price/Sales (ttm) | 4.63 |
| Price/Book (mrq) | 4.80 |
| Enterprise Value/Revenue | 4.81 |
| Enterprise Value/EBITDA | 21.46 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.74 |
| 52-Week Change 3 | -3.27% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 121.64 |
| 52 Week Low 3 | 89.67 |
| 50-Day Moving Average 3 | 113.75 |
| 200-Day Moving Average 3 | 106.69 |
Share Statistics
| Avg Vol (3 month) 3 | 5.83M |
| Avg Vol (10 day) 3 | 6.27M |
| Shares Outstanding 5 | 1.74B |
| Implied Shares Outstanding 6 | 1.74B |
| Float 8 | 1.72B |
| % Held by Insiders 1 | 0.54% |
| % Held by Institutions 1 | 77.01% |
| Shares Short (Apr 15, 2024) 4 | 12.94M |
| Short Ratio (Apr 15, 2024) 4 | 1.88 |
| Short % of Float (Apr 15, 2024) 4 | 0.75% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.75% |
| Shares Short (prior month Mar 15, 2024) 4 | 15.72M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2.2 |
| Forward Annual Dividend Yield 4 | 2.06% |
| Trailing Annual Dividend Rate 3 | 2.12 |
| Trailing Annual Dividend Yield 3 | 1.98% |
| 5 Year Average Dividend Yield 4 | 1.59 |
| Payout Ratio 4 | 64.80% |
| Dividend Date 3 | May 15, 2024 |
| Ex-Dividend Date 4 | Apr 12, 2024 |
| Last Split Factor 2 | 10000:4798 |
| Last Split Date 3 | Jan 02, 2013 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 13.96% |
| Operating Margin (ttm) | 14.06% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 40.33B |
| Revenue Per Share (ttm) | 23.18 |
| Quarterly Revenue Growth (yoy) | 2.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 10.34B |
| Net Income Avi to Common (ttm) | 5.61B |
| Diluted EPS (ttm) | 3.21 |
| Quarterly Earnings Growth (yoy) | -7.10% |
Balance Sheet
| Total Cash (mrq) | 7.28B |
| Total Cash Per Share (mrq) | 4.2 |
| Total Debt (mrq) | 15.87B |
| Total Debt/Equity (mrq) | 40.88% |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 22.26 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.